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COVER   Center for Cellular Imaging 
equipment reveals Staphylococcus aureus 
bacteria (purple) on the surface of a 
catheter. The bacteria release the enzyme 
urease, which hydrolyzes urea resulting in 
crystal formation (gold) and the protein 
fibrinogen (teal). This helps protect the 
bacteria from immune cells (tan) and 
antibiotics. See page 21. 
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William Danforth, MD, then vice 
chancellor for medical affairs, 
at the McDonnell Hall ground-
breaking ceremony in 1967. 
Danforth and others decided to 
keep the medical center in the 
city, even as the neighborhood 
faltered. See page 9.
The Department of Ophthalmology has been 
renamed in honor of John F. Hardesty, MD.  
A $10 million gift from his daughter is funding  
research and patient care and recognizing 
Hardesty’s legacy of service. See page 30.
Park rangers in Missouri are joining 
the fight against the opioid epidemic. 
Above, rangers listen as David Tan, 
MD, chief of the emergency medical 
services section, talks about the crisis. 
Increasingly, overdoses are occurring in 
public parks. See page 14.
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isrupting just one night of sleep 
in healthy, middle-aged adults 
causes an increase in amyloid 
beta, a brain protein associated with 
Alzheimer’s disease, according to a study 
from the School of Medicine, Radboud 
University Medical Centre in the Netherlands 
and Stanford University. And a week of 
tossing and turning leads to an increase in 
tau, another brain protein that has been 
linked to Alzheimer’s and other 
neurological diseases.
 “We think that perhaps chronic poor 
sleep during middle age may increase the 
risk of Alzheimer’s later in life,” said David 
M. Holtzman, MD, the Andrew B. and 
Gretchen P. Jones Professor, head of the 
Department of Neurology and the study’s 
senior author. These findings were 
published July 10 in the journal Brain.
For this study, 17 healthy adults ages 35 
to 65 with no sleep problems or cognitive 
impairments wore a wrist activity monitor 
for up to two weeks, which measured how 
much time they spent sleeping. 
Each participant also spent a night in 
sleep rooms at the medical school, where 
they wore headphones over the ears and 
scalp electrodes to monitor brain waves. 
Half the participants were assigned to  
have their sleep disrupted during the night. 
Every time their brain signals settled into 
the slow-wave pattern characteristic of 
deep, dreamless sleep, the researchers sent 
a series of beeps through the headphones, 
gradually getting louder, until the participants’ 
slow-wave patterns dissipated and they 
entered shallower sleep. 
Slow-wave sleep is when neurons rest 
and the brain clears away the molecular 
byproducts of mental activity.
The next morning, the participants who 
had been beeped out of slow-wave sleep 
reported feeling tired and unrefreshed,  
even though they had slept just as long as 
usual. Each underwent a spinal tap so the 
researchers could measure the levels of 
amyloid beta and tau in the fluid 
surrounding the brain and spinal cord.
A month or more later, the process was 
repeated, except that those who had their 
sleep disrupted were allowed to sleep 
through the night undisturbed, and those 
who had slept uninterrupted were 
disturbed by beeps.
The researchers compared participants’ 
amyloid beta and tau levels after the disrupted 
night to the levels after the uninterrupted 
night. They found a 10 percent increase in 
amyloid beta levels after a single night of 
interrupted sleep, but no corresponding 
increase in tau levels. However, participants 
whose activity monitors showed they had 
slept poorly at home for the week before 
the spinal tap showed a spike in tau levels. 
Yo-El Ju, MD, co-first author and an 
assistant professor of neurology, said it is 
unlikely that a night or even a week of poor 
sleep has much effect on overall risk of 
developing the disease. “The main concern 
is people who have chronic sleep 
problems,” Ju said. 
Alzheimer’s, sleep connection
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Brain waves during slow-wave sleep, measured as 
a study participant slept.
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Alzheimer’s, sleep connection
To blunt postoperative pain and reduce the need for opioid 
drugs following surgery, anesthesiologists oen give patients 
low doses of the drug ketamine during operations. 
But a new study led by anesthesiologists at the School of 
Medicine and the University of Michigan Medical School 
indicates that ketamine doesn’t lower pain levels or reduce 
the need for pain-killing opioid drugs in the days aer an 
operation. Further, older patients who receive ketamine 
during surgery are more likely to experience hallucinations 
and nightmares in 
the recovery room 





online May 30 in 
the journal e 
Lancet.
“We found 
that the current 
practice of 
giving low doses of ketamine to patients during surgery 
is not having the desired eect,” said rst author Michael 
S. Avidan, MBBCh, the Dr. Seymour and Rose T. Brown 
Professor of Anesthesiology at Washington University. “So 
we need to determine whether higher doses might be more 
eective, or we need to nd alternatives to opioids.”
Avidan, with co-principal investigator George A. Mashour,  
MD, PhD, an anesthesiology professor at the University of 
Michigan Medical School, led a study aimed at evaluating  
ketamine as a way to prevent delirium and other complications.  
In previous research, Avidan had found that up to 20 percent 
of older patients experienced delirium following surgery.
e researchers followed 672 surgery patients in four 
countries: the U.S., Canada, India and South Korea. During 
surgery, the patients — all at least 60 years of age — either 
received no ketamine, a very low dose of the drug, or a 
slightly higher dose. e doses of ketamine given in the 
study are the doses routinely given to surgery patients 
by anesthesiologists who want to lower patients’ levels of 
postoperative pain.
Avidan said the fact that the study results were consistent 
at dierent sites in dierent countries makes him condent 
that current ketamine practices are not having the desired 
eect on delirium and postoperative pain. He said clinicians 
should reconsider the common practice of giving low doses 
of ketamine during surgery.
Study: Ketamine does not 







Robyn S. Klein, MD, PhD, a physician-scientist recognized 
internationally for her work on the brain’s immune system, 
has been named vice provost and associate dean for graduate 
education for the Division of 
Biology & Biomedical Sciences 
(DBBS), eective Jan. 1.
Klein succeeds John H. Russell, 
PhD, who is retiring but will 
retain an appointment in 
developmental biology, and 
plans to revitalize the Oce  
of Postdoctoral Aairs.
Widely emulated for its 
interdisciplinary approach to 
training PhD scientists, DBBS 
crosses both the Danforth and Medical campuses. It brings 
together about 525 faculty members from 37 departments in 
the School of Medicine, Arts & Sciences and the School of 
Engineering & Applied Science who teach and mentor some 
500 graduate students, making it the largest PhD program at 
the university.
As associate dean, Klein will set the direction of graduate 
education at DBBS. She also will be the rst associate dean 
of graduate education to hold the title of vice provost, a 
change in governance that recognizes the status of DBBS as 
a universitywide academic endeavor. Klein intends to build 
on the division’s strength in training young scientists, and 
to prepare students for interdisciplinary careers that extend 
beyond academic domains. Klein also plans to increase 
recruitment of underrepresented students. 
Klein to head PhD training program
EMPOWERING WOMEN Incoming female residents in 
internal medicine gather for a networking event sponsored by 
the Forum for Women in Internal Medicine (FWIM). Created in 
2014, FWIM supports the professional and personal development 
of women trainees in the Department of Medicine. The group 
hosts career workshops and lectures, facilitates mentoring 
opportunities and fosters a sense of camaraderie.  















Anesthesiologists routinely give surgery patients low 
doses of the drug ketamine. 
Robyn S. Klein, MD, PhD
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A child’s chance of developing Type 1 diabetes may 
be inuenced by the viruses that live in his or her gut, 
according to a new study. 
“We identied one virus that was signicantly associated 
with reduced risk, and another group of viruses that was 
associated with increased risk of developing antibodies 
against the children’s 
own cells,” said 
Herbert “Skip” 
Virgin IV, MD, 
PhD, the Edward 
Mallinckrodt 
Professor and head 
of Pathology and 
Immunology, and 
the study’s senior 
author. “It looks 
like the balance of 
these two groups 
of viruses may 
control the risk of 
developing the antibodies that can lead to Type 1 diabetes.”
e ndings suggest a way to predict, and maybe even 
prevent, the life-altering diagnosis.
Type 1 diabetes develops as a two-step process. First, 
people acquire antibodies against their own pancreatic cells 
responsible for producing insulin, a hormone that allows 
cells to absorb sugar from the bloodstream. Some children 
generate the auto-antibodies but never develop disease.
In other children, however, the auto-antibodies signal an 
attack by the body’s own immune system on the pancreas 
that leads to Type 1 diabetes.
Virgin and colleagues examined stool samples obtained 
from birth to age 3 from children whose genes put them at 
high risk of developing Type 1 diabetes. ey matched 11 
children who went on to acquire auto-antibodies — ve of 
whom later developed Type 1 diabetes — with 11 children 
who did not develop auto-antibodies or the disease. 
A previously unknown virus related to circoviruses was 
found in ve of the 11 children who did not develop auto-
antibodies, but not in any of the children who did. 
e researchers also found dierences in a group of viruses 
called bacteriophages that infect bacteria, not human cells. 
Children carrying bacteriophages that target the Bacteroides 
species — one of the major groups of intestinal bacteria — 
were more likely to start down the path toward diabetes.
Study links intestinal 
viruses to diabetes
Herbert “Skip” Virgin IV, MD, PhD, talks with post-
doctoral researcher Dale Balce, PhD. 








Matthew Carothers, 13, a patient with Johanson-
Blizzard syndrome, recently met the doctor who 
discovered the extremely rare congenital condition. 
Short and thin for his age, Carothers rst came to 
Washington University at age 5 for thyroid problems. 
Geneticist Kathy Grange, MD, a professor of pediatrics, 
recognized the syndrome, which causes pancreatic 
insuciency. With diagnosis and treatment, his quality 
of life has greatly improved. Over the years, Grange 
said she wished she could discuss Carothers’ medical 
issues with Ann Johanson, MD, who co-named the 
syndrome with mentor Robert Blizzard, MD, in 1972. 
Unbeknownst to Grange, Johanson was living in the  
St. Louis area. Upon realizing this through Facebook 
connections, nurse practitioner Susan Davis invited 
Johanson to the Medical Campus. 
NEW ACADEMY MEMBERS   In recognition of their 
distinguished achievements in original research, L. David Sibley,  
PhD (left), and David C. Van Essen, PhD, recently were elected to  
the National Academy of Sciences. Election is considered one of  
the highest honors accorded a U.S. scientist or engineer. Sibley, the 
Alan A. and Edith L. Wolff Distinguished Professor of Molecular 
Microbiology, is an expert on the cellular microbiology of parasites. 
Van Essen, the Alumni Endowed Professor of Neurobiology, studies the 








Boy meets doctor who 
named his rare condition 
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opular heartburn drugs called 
proton pump inhibitors (PPIs) are 
linked to a higher death risk, a new 
study shows. This risk increases the longer the 
drugs are used. 
The research is published online July 3 in 
the journal BMJ Open.  
Doctors widely prescribe PPIs to treat  
ulcers and other gastrointestinal problems. 
PPIs, under brand names such as Prevacid, 
Prilosec and Nexium, also are available over  
the counter. Both PPIs and H2 blockers, another  
class of drug, are prescribed for serious medical 
conditions such as upper gastrointestinal 
tract bleeding, gastroesophageal reflux 
disease and esophageal cancer. 
A kidney doctor by profession, senior 
author Ziyad Al-Aly, MD, previously has 
published studies linking PPIs to kidney 
disease. Studies from unrelated groups have 
associated PPI use with health problems 
ranging from bone fractures to dementia.
Popular heartburn drugs tied to higher death risk
Risk increases the longer the drugs are used
P Al-Aly, first author Yan Xie, PhD, a data scientist, and colleagues reasoned that, cumulatively, these side effects may affect  
the mortality rate of PPI users.
To find out, the researchers sifted through 
millions of de-identified veterans’ medical 
records in a database maintained by the 
U.S. Department of Veterans Affairs. They 
identified 275,933 people who had been 
prescribed a PPI and 73,355 people prescribed 
an H2 blocker between October 2006 and 
September 2008, and noted how many died 
and when over the following five years.
 “No matter how we sliced and diced the 
data from this large data set, we saw the 
same thing: There’s an increased risk of death 
among PPI users,” said Al-Aly. 
Al-Aly and colleagues found a 25 percent 
increased risk of death in the PPI group 
compared with the H2 blocker group. Among 
people taking the drugs for one to two years, 
the risk to PPI users was nearly 50 percent 
higher than that of H2 blocker users.
The researchers estimate that, for every 500 
people taking PPIs for a year, there is one extra 
death that would not otherwise have occurred.
Although the recommended treatment 
regimen for most PPIs is short — two to eight 
weeks for ulcers, for example — many people 
end up taking the drugs for months or years.
“A lot of times people get prescribed PPIs 
for a good medical reason, but then doctors 
don’t stop it and patients just keep getting 
refill after refill after refill,” Al-Aly said. “There 
needs to be periodic re-assessments as to 
whether people need to be on these.” 
Over-the-counter PPIs contain the same 
compounds as prescription PPIs, just at lower 
doses. The Food and Drug Administration 
recommends taking PPIs no longer than four 
weeks before consulting a doctor.
Millions of Americans take  
proton pump inhibitors for 









173043_p2-8_Pulse v8_cc17.indd   5 8/30/17   9:44 AM
Autumn 20176  Washington University School of Medicine
Helen McNeill, PhD, is the rst researcher named as a  
BJC Investigator at the School of Medicine. e new  
BJC Investigators Program aims to recruit scientists  
who bring innovative approaches to major biological 
quandaries and whose discoveries stand to inform new 
ways of understanding disease and developing treatments.
McNeill, an international leader in the eld of 
developmental biology, is a professor in the Institute 
of Medical Science and the Department of Molecular 




Institute, part of 
the Sinai Health 
System in Toronto. 
Her appointment as 
a BJC Investigator 




candidates who had 
already indelibly 
changed their elds, whose discoveries will result in new 
and fundamental shis in scientic thinking and whose 
laboratories will become a nidus for additional innovative 
work across Washington University,” said David H. 
Perlmutter, MD, executive vice chancellor for medical 
aairs and dean of the School of Medicine.  
e program is designed to specically focus on 
basic science and is inspired by the Howard Hughes 
Medical Institute’s philosophy of investing in people with 
exceptional creative talent. It plans to bring 10 renowned 
researchers to the School of Medicine and the life sciences 
ecosystem of St. Louis.
 “is program represents another joint eort between 
BJC and Washington University to help keep the school’s 
biomedical research at the forefront of discovery,” said 
Steven H. Lipstein, CEO of BJC HealthCare. 
McNeill’s work is focused on understanding the 
processes that govern how cells make contact and work 
together to form the broader architecture of whole tissues, 
both during development and adulthood. Her work — 
spanning studies of fruit ies, mice and human genetic data 
— has relevance for understanding birth defects, cancer and 
diseases of specic organs, such as the kidney and lungs.















Helen McNeill, PhD, is an international leader in 
the field of developmental biology.
          
A new study shows that a particular gut microbe can prevent 
severe flu infections in mice, likely by breaking down naturally 
occurring compounds — called flavonoids — commonly  
found in foods such as black tea, red wine and blueberries.
The research, conducted in mice by School of Medicine 
scientists, also indicates that this strategy is effective in staving 
off severe flu damage when the interaction occurs prior to 
infection with the virus. This work also could help explain the 
wide variation in human responses to influenza infection.
The study is published in the journal Science.
“For years, flavonoids have been thought to have protective 
properties that help regulate the immune system to fight 
infections,” said first author Ashley L. Steed, MD, PhD, an 
instructor in pediatrics who treats intensive care patients at  
St. Louis Children’s Hospital. 
Previous evidence suggests that the gut microbiome may 
be important in protecting against severe influenza infections, 
so in this study, the researchers aimed to identify just what gut 
microbes might provide that protection. 
“We were able to identify at least one type of bacteria that 
uses these dietary compounds to boost interferon, a signaling 
molecule that aids the immune response,” said the study’s 
senior author, Thaddeus S. Stappenbeck, MD, PhD, the Conan 
Professor of Pathology & Immunology. 
This prevented influenza-related lung damage in the mice. It 
is this kind of damage that often causes significant complications 
such as pneumonia in people.
As part of the study, the researchers screened human  
gut microbes looking for one that metabolized flavonoids. 
Stappenbeck and Steed identified one such microbe that  
they suspected might protect against flu damage. 
The microbe, called Clostridium orbiscindens, degrades 
flavonoids to produce a metabolite that enhances  
interferon signaling.
“The metabolite is called desaminotyrosine, otherwise 
known as DAT,” Steed said. “When we gave DAT to mice and 
then infected them with influenza, the mice experienced far 
less lung damage than mice not treated with DAT.”
Next steps include identifying other gut microbes that may use 
flavonoids to influence the immune system, as well as exploring 
ways to boost the levels of those bacteria in people whose 
intestines aren’t adequately colonized with those microbes. 
Gut microbes, flavonoids 
protect against severe flu
Flavonoids are commonly 
found in foods such as black 
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tudying pregnant mice, School of 
Medicine researchers have learned 
that the Zika virus infects the fetus 
by manipulating the body’s normal barrier 
to infection. Moreover, they showed that a 
malaria drug can interfere with this process, 
protecting the fetus from viral infection. 
“We found that the malaria drug 
hydroxychloroquine effectively blocks 
viral transmission to the fetus,” said senior 
author Indira Mysorekar, PhD, an associate 
professor of obstetrics and gynecology 
and of pathology and immunology. “This 
drug already is used in pregnant women 
to treat malaria, and we suggest that it 
warrants evaluation in primates and women 
to diminish the risks of Zika infection and 
disease in developing fetuses.”
The findings are published in The  
Journal of Experimental Medicine.
To protect the developing fetus from 
infection, the body mobilizes robust defenses 
that keep microbes from ever reaching the 
fetus in the first place. 
Mysorekar and others have shown that 
autophagy — the cellular waste-disposal 
pathway by which cells grind up debris, 
unwanted organelles and invading microbes 
— is an important part of the formidable 
placental barrier to infection. 
Malaria drug protects fetuses from Zika infection
Treatment prevents virus from crossing placenta to infect fetus, mouse study shows
S Zika, however, not only can invade the placenta, but it 
can multiply there, 
Mysorekar and others 
have found.
To understand 
how Zika breaches the 
placenta, Mysorekar, 
postdoctoral fellow 
Bin Cao, PhD, and 
colleagues infected 
human placental cells 
with the virus. Exposure 
to the virus activated 
genes related to 
autophagy, they found.
However, when the 
researchers treated the cells with drugs to 
ramp up the autophagy pathway, the number 
of Zika-infected cells increased. Drugs that 
suppressed autophagy resulted in fewer 
placental cells infected with Zika virus. In 
other words, the virus spread more effectively 
when the researchers dialed up the barrier 
response, and performed more sluggishly 
when they dialed it down. 
Since hydroxychloroquine suppresses 
the autophagy response, the researchers 
questioned whether it also could protect 
fetuses against Zika. The researchers dosed 
Zika-infected pregnant mice with either 
hydroxychloroquine or a placebo. They found 
significantly less virus in the fetuses and 
placentas from the mice that had received 
hydroxychloroquine. In addition, these 
placentas showed less damage and the 
fetuses regained normal growth. 
OUTmed
Supporting LGBTQ rights
To help LGBTQ faculty, staff and students develop networking 
relationships and find mentors, the Department of Medicine 
recently launched OUTmed. One of its first priorities was to create 
OUTlist, a visible listing of medical school faculty, staff, house 
staff and students who identify as members of the LGBTQ  
community, and an ALLYlist of those who support LGBTQ rights 
and equality. OUTmed is committed to bringing national best 
practices in LGBTQ health care to the medical school. Left, OUTmed 
supporters marched in the St. Louis PrideFest parade June 25. 
Learn more at internalmedicinediversity. 
wustl.edu/outmed
Left: The malaria drug chloroquine — a close relative  
of hydroxychloroquine — prevents the Zika virus 
(green) from growing in human placental cells (blue).   
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Eva Aagaard, MD, formerly a professor of medicine and 
associate dean for educational strategy at the University 
of Colorado School of Medicine, has been named senior 
associate dean for education.  
“Eva is a visionary 
with a glowing  
reputation nationally  
and internationally 
for her leadership and 
innovation in medical 
education,” said David H. 
Perlmutter, MD, executive 
vice chancellor for 
medical aairs and dean 
of the School of Medicine. 
Aagaard succeeds 
Alison J. Whelan, 
MD, who joined the 
Association of American 
Medical Colleges (AAMC) as its new chief medical 
education ocer. Mary E. Klingensmith, MD, the Mary 
Culver Distinguished Professor of Surgery and vice chair 
for education in the Department of Surgery, served as senior 
associate dean for education in the interim.
At the University of Colorado, Aagaard founded the 
Academy of Medical Educators, which works to promote 
teaching excellence through faculty certicate programs in 
medical education and leadership, one-on-one coaching, a 
longitudinal and online curriculum for faculty development 
and a residents-as-teachers program, among other initiatives. 
Aagaard also directed the Center for Advancing Professional 
Excellence, a standardized patient and simulation center.
Aagaard has served in national leadership positions with 
the American Board of Internal Medicine, National Board 
of Medical Examiners and the Society of General Internal 
Medicine. In those roles, she has collaborated with the 
AAMC and the Accreditation Council for Graduate Medical 
Education. A noted mentor for women in medicine, Aagaard 
works with dozens of committees and programs nationally 
and at the university level. “Mentoring women is important 
because they oen lack access to mentors,” she said. “Having 
a trusted colleague to help pinpoint priorities and identify 
ways to achieve goals can help them overcome unique 
challenges.”
She and her husband, Russ Aagaard, a small-business 















HOWARD HUGHES FELLOWS Medical students 
Rukayat Taiwo (left) and Connor Liu have been selected to 
receive a year of mentored training with top biomedical 
scientists through the Howard Hughes Medical Institute’s 
Medical Research Fellows Program. Taiwo is one of seven 
fellows to receive funding for a second year. She is analyzing 
glioblastoma on a molecular level with mentors Albert H. Kim, 
MD, PhD, and Joshua B. Rubin, MD, PhD. Liu is working with 
mentor Gavin P. Dunn, MD, PhD, to test computational strategies 
that may be used to design therapeutic cancer vaccines.
Larry J. Shapiro, MD, dean 
emeritus of the School of  
Medicine, is the new chief  
executive ocer of University 
Health Partners of Hawaii, the 
faculty practice at the University  
of Hawaii John A. Burns School  
of Medicine. 
A pediatrician, genetics 
researcher and mentor, Shapiro 
served as executive vice chancellor 
for medical aairs and dean of the School of Medicine from 
2003 to 2015. “Serving Washington University School of 
Medicine has been an enormous privilege,” Shapiro said. 
“It is a remarkable place, with many amazing and talented 
individuals who work, study and teach here. I have been 
associated with Washington University for more than 50 
years as a student, a parent and a faculty member. I owe an 
enormous debt to the many people that have meant so much 
to me during that span of time.”
Shapiro said he plans to return to St. Louis oen and 
represent the university in Japan for the McDonnell 
International Scholars Academy.
Dean emeritus to lead University 
of Hawaii faculty practice
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Anchor 
How medical center visionaries helped save the Central West End 
Top: Over a century old, the Central West 
End, which abuts Washington University 
Medical Campus, is full of charming cafés, 
galleries, antique shops, restaurants 
and boutiques. A new book outlines the 
neighborhood’s origins, period of aﬄuence, 
decline and revitalization. Bottom: Delmar 






















173043_p9-13_CWE v12_cc17.indd   9 8/30/17   11:55 AM
10  Washington University School of Medicine Autumn 2017
n ambitious new book traces the rise, fall and resurrection 
of the Central West End, the historic neighborhood 
near Washington University Medical Campus. 
Impetus for the book came from William H. Danforth,  
MD, university chancellor from 1971 to 1995 and former  
vice chancellor for medical aairs. Danforth said he felt it  
was important to highlight the medical center’s crucial role  
in saving its own neighborhood and staying in the city even  
as crime escalated and the area faltered.
“Renaissance: A History of the Central West End” is a  
320-page coee table book written by St. Louis author  
Candace O’Connor and published by Reedy Press.
Compton and Dry’s view of St. Louis, 1875
Candace O’Connor has written extensively on 
the history of the university and the medical 
center. Among many others, her books 
include: “Beginning a Great Work: Washington 
University in St. Louis, 1853–2004,” “A Surgical 
Department of Distinction: 100 Years of 
Surgery at Washington University School of 
Medicine,” “Imaging & Innovation: A History  
of Mallinckrodt Institute of Radiology,”  
“Hope and Healing: St. Louis Children’s 
Hospital” and the forthcoming “A Legacy of 
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What was the Central West End like before the 
School of Medicine was built?
By the time the new Washington University  
School of Medicine campus was dedicated in 1915, 
the Central West End (CWE) was by far the most 
desirable neighborhood in St. Louis. In 1875, when 
Compton and Dry created their famous bird’s-
eye views of the city, the CWE had been a sleepy, 
rural place, mostly farmland. But in the run-up to 
the 1904 World’s Fair, and in the booming years 
aerward, that changed dramatically. High-end 
builders developed beautiful streets, including 
private places, along with chic commercial districts. 
Robert Brookings, the university board chairman 
who moved the medical school from downtown  
St. Louis to Kingshighway, bought a home for 
himself on Lindell, across from Forest Park. 
Religious congregations moved in, as did other 
hospitals. Many of the city’s elite settled in CWE 
houses, including such noted School of Medicine 
physicians as Washington Fischel, George Gellhorn, 
W. McKim Marriott, Evarts Graham and Vilray 
Blair. A 1912 book, published by a local newspaper, 
listed the 4,000 most famous men in St. Louis — 
and most of them lived in the CWE.
As the medical school and its affiliate hospitals 
grew and prospered, what was happening in the 
neighborhood around it? 
During the teens, 1920s and into the 1930s, the CWE 
ourished. Prominent people, such as David Francis  
— who was chief World’s Fair organizer, St. Louis  
mayor, Missouri governor and ambassador to Russia 
— lived in giant houses, staed by uniformed 
servants. At Kingshighway and Lindell, the William 
Bixby family owned the entire block and lived in 
a palatial home that later was demolished to make 
way for the elegant Chase and Park Plaza hotels.
When and why did the downturn in the 
neighborhood begin?
In 1927, a powerful tornado devastated parts of 
the CWE, killing 78 people and injuring 500. On 
many days, a pall of smoke, caused by coal res and 
industrial pollution, hung over the area, and some 
residents began to look toward new suburbs with 
cleaner air. During the 1930s-era Depression, some 
of the large homes became unaordable. en at the 
end of World War II, the crush of returning soldiers 
created a huge demand for housing. Suddenly, owners 
had a great incentive to break up these large homes 
into rooming houses. In the 1950s and 1960s, some 
mansions were torn down for modern high-rises or 
even parking lots.  
What was the Central West End’s low point?
By the 1960s and early 1970s, the situation in  
the CWE had become critical. As Dr. Ron Evens 
(former head, Mallinckrodt Institute of Radiology, 
and former president, Barnes-Jewish Hospital) 
said: “People don’t realize when you go to the 
CWE now, what it was like then. It was seedy. It 
was dirty. It was high crime. It was prostitutes. 
It was people drunk on the streets. So the issue 
became, ‘Oh, my God, what are we going to do 
about that?’” Dr. Will Ross (nephrologist and 
associate dean) said that when he was here for 
a medical school interview, he was walking 
down Kingshighway when a policeman behind 
him began shooting at a man in front of him. 
In 1962, the medical center institutions banded 
together, forming the organization later called the 
Washington University Medical Center. Still crime 
was a serious problem for employees, who were 
being robbed on the streets. Other hospitals —  
St. John’s, Shriners, Missouri Baptist and St. Luke’s 
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What did Washington University Medical Center 
do about it?
During the 1960s, Dr. William Danforth, then 
vice chancellor for medical aairs, began to worry 
about the ight of these hospitals and the fancy 
new “Palaces on Ballas” they were building in the 
western suburbs. He tapped the talented young  
Dr. Evens to head a committee that would consider 
three options: move the medical center west, 
stay put, or remain in place but build a clinical 
presence in the Plaza Frontenac area. Raymond 
Wittco (developer and Jewish Hospital board 
member) was a major advocate for staying in the 
city, and ultimately that view prevailed. Next 
Wittco contacted an architectural rm to design 
a plan for the Central West End. But the proposal 
called for razing a huge swath of the area — and 
somehow it was leaked to a local newspaper. 
People living in the neighborhood, who were 
working hard to save it, were horried.
What did the medical center try next?
ey needed a new approach. So Dr. Danforth, 
who became university chancellor in 1971, had  
lunch with developer Richard Rolo, then working  
for Capitol Land Company, and he generously 
agreed to take on volunteer leadership of a new 
revitalization eort. He did a spectacular job, 
though it was tough going. At his rst meeting 
with residents, he encountered a crowd still 
angry from the newspaper article. As he recalled, 
every one of those people would cheerfully have 
bought him a one-way ticket to California! But 
he persisted, hiring urban design rm Team 
Four to devise a plan that would save as much 
historic architecture as possible, acquire homes 
from residents ready to leave and re-sell them to 
young buyers, eager to renovate. He and his team 
also brought in a major client, Blue Cross, to new 
headquarters that later became the 4444 building 
on Forest Park Avenue. 
How successful was this revitalization effort?
It was extraordinarily successful. e Washington 
University Medical Center Redevelopment 
Corporation (WUMCRC) — headed successively 
by executive directors Jerry King, Eugene Kilgen 
and others — worked in partnership with area 
residents and the medical center, particularly 
psychiatrist Dr. Samuel Guze, who succeeded 
Dr. Danforth as vice chancellor for medical 
aairs. ey bought up dilapidated homes, such 
as those on the 4300 and 4400 blocks of Laclede; 
oen the elderly owners would greet them at the 
door and say gratefully, “Where do I sign?” en 
they attracted young families — even the new 
superintendent of the St. Louis schools — to buy 
and rehab them. A diverse group of people moved 
in. ey also encouraged new businesses to come 
in. Of course, the medical school and the hospitals 
have since thrived and grown substantially, with 
more than 20,000 people working there daily. One 
surprise has been that the WUMCRC, initially 
viewed as a decade-long eort, continues today 
under executive director Brian Phillips. e CWE 
now is a vibrant mix of historic buildings and new 
development.
How does the future look for the Central West End 
and surrounding neighborhoods?
e future of the CWE is very bright, and its 
success also has been a catalyst for growth in other 
neighborhoods. e Forest Park Southeast area, 
now known as e Grove, began a major renewal 
under the leadership of William Peck, then dean 
of the medical school, and Dr. Jerry Flance, who 
worked with residents and urban pioneers. And 
the new Cortex Innovation Community, a 200-acre 
technology district to the east, developed there in 
part because startup businesses liked the proximity 
to the medical center and to the diverse, exciting 
CWE. Today, Cortex is one of the fastest growing 
technology startup scenes in the U.S., with more 
than 250 companies on site. So the WUMCRC’s 
valiant eorts in the 1970s and beyond have 
certainly had a wide-reaching impact.
“ That decision (to stay) may be one of 
the five most important decisions ever 
made in terms of the history of the city 
of St. Louis. Because if the Washington 
University Medical Center had left … can 
you imagine what the city of St. Louis 
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Art gallery in William Bixby’s palatial home, c. 1904
Dr. Carl Moore lectures in Barnes Amphitheater, 1943
World Chess Hall of Fame, 2015 Solae/DuPont Headquarters in Cortex Innovation Community, 2010
Dining today in the Central West End 
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eodore Cicero’s research changed direction when he encountered a 
20-year-old who was taking opioids — but not to get high.
e young man was struggling with depression, low self-esteem and 
social anxiety. He was taking drugs because he believed they made him a 
better, more popular person. He was more social, more relaxed and was 
able to approach women in bars and start conversations. And he was taking 
opioids despite the disastrous consequences he knew they could have.
Cicero, PhD, the John P. Feighner Professor of Psychiatry, has surveyed 
25,000 addicts on why they use drugs. It’s stories like the young man’s that 
illuminate the challenge medical professionals face in ghting drug use.
Inside an epidemic
B Y  G A I A  R E M E R O W S K I
Overcoming America’s opioid crisis starts with  
understanding abuse patterns









173043_p14-20_Opioid v12_cc17.indd  15 8/30/17  10:40 AM
16  Washington University School of Medicine Autumn 2017
P A I N  S C A L E
The Joint Commission suggests 
pain is vastly undertreated and 
urges doctors to consider it as 
the “fifth vital sign.” 
M I S I N F O R M A T I O N
A now-debunked letter in 
The New England Journal 
of Medicine deems painkillers 
as rarely addictive.
O P I A T E  E X P L O S I O N
Doctors prescribe larger amounts of opioids, 
which end up on the street. An extended-
release version of OxyContin containing 
10 times more active ingredient is developed, 
making it easier to crush and snort.
S U P P L Y  L I M I T S
As doctors realize the 
abuse potential, they limit 
prescriptions, decreasing 
supply and increasing costs 
of opioids on the streets. 
D E T E R R E N C E  E F F O R T S
Drug company makes a version of 
OxyContin that is more difficult to 
crush and snort. This inadvertently 
drives addicts to heroin.
H E R O I N
The epidemic increases over 
time. Addicts’ demographics shift 
from poor, predominantly black 
communities to more white, middle- 
to upper-class communities.
F E N T A N Y L
Dealers realize cutting heroin with the 
far more potent, cheaper, lab-made 
opioids fentanyl and carfentanil gives 
users a better — but often fatal — high.
From pain pills to heroin  
How misunderstandings and good intentions 
drove the worst drug crisis in U.S. history
?
The typical survey response is not that they are getting high, but that it relieves their depression, they feel less anxious,” Cicero 
said. “Many people feel they are actually better 
individuals when they’re taking drugs because they 
are more outgoing. People think they function better. 
at’s a dicult thing to combat.” 
is is the power opioids, such as the prescription 
pain pill oxycodone or the more easily obtained 
illegal heroin, have on many individuals and is one 
major reason the drugs are so addictive. In 2014, 
drug overdoses surpassed automobile accidents 
as the No. 1 cause of accidental death for the rst 
time in U.S. history. And although not all of these 
overdoses are due to opioids, 91 Americans die 
every day from an opioid overdose, according to 
the Centers for Disease Control and Prevention 
(CDC). CDC data also show that 60 percent 
of overdoses occur in patients with legitimate 
prescriptions from a single doctor.
For 25 years, Cicero has been ahead of this 
developing crisis, charting addicts’ motivations 
and predicting emerging abuse patterns around 
the country. Cicero and colleagues were the rst 
to identify changing demographics as opioid 
addiction spread from inner cities to the suburbs, 
and also predicted the shi from painkillers to 
heroin to synthetic opioids like fentanyl.
How did we get here?
“ere are two events that happened in the late 
’90s and early 2000s that have led to where we are 
right now,” Cicero said. 
In 2001, the Joint Commission accrediting 
organization, advocating on behalf of patients, 
issued a set of standards outlining how the health-
care industry was vastly undertreating pain. e 
report recommended that health-care workers 
consider pain as the “h vital sign,” along with 
monitoring of a patient’s temperature, pulse, 
respiration and blood pressure. 
As a result, health-care workers routinely began 
asking patients to rate their pain on a pain scale. 
e overarching message: patients shouldn’t have 
to endure pain.
e report also urged physicians to prescribe 
opioids more freely, based on a letter published 
in 1980 in e New England Journal of Medicine 
(NEJM). Written by two doctors, the ve-sentence 
letter stated: “We conclude that despite widespread 
use of narcotic drugs in hospitals, the development 
of addiction is rare in medical patients with no 
history of addiction.” ough the letter since has 
been debunked, drug makers and doctors still 
cite it as a reason to continue the widespread 
prescribing of opioids. 
Another event that took abuse to a critical level 
was the 1996 introduction of an extended-release 
version of oxycodone, one of the most popular 
opioid painkillers. 
Sold under the brand name OxyContin, the 
new pills could be taken just once or twice a day, 
rather than every 4 to 6 hours. “For people who 
had trouble keeping track of their medications, 
this was an ideal solution,” Cicero said. “Elderly 
people, for example, especially have memory 
issues with that.” 
is new formulation, however, also was an 
ideal solution for addicts. For a pill to work over 
24 hours, it must contain a large amount of the 
active drug. Instead of 5 mg, each tablet now 
contained 80 to 100 mg of oxycodone. Addicts 
soon learned they could release the drug’s full 
potency all at once by crushing the new tablets.
e revised formulation also contained 
no acetaminophen or non-steroidal anti-
inammatory drugs, both of which make 
snorting and injecting the drug very painful. 
(Acetaminophen, for instance, burns the nasal 
passages when snorted.)
For more than 25 years, 
psychiatrist Theodore 
Cicero, PhD, has been  
on the leading edge of  
the opioid epidemic,  
surveying some 25,000 
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pain is vastly undertreated and 
urges doctors to consider it as 
the “fifth vital sign.” 
MISINFORMATION
A now-debunked letter in 
The New England Journal 
of Medicine deems painkillers 
as rarely addictive.
OPIATE EXPLOSION
Doctors prescribe larger amounts of opioids, 
which end up on the street. An extended-
release version of OxyContin containing 
10 times more active ingredient is developed, 
making it easier to crush and snort.
SUPPLY LIMITS
As doctors realize the 
abuse potential, they limit 
prescriptions, decreasing 
supply and increasing costs 
of opioids on the streets. 
DETERRENCE EFFORTS
Drug company makes a version of 
OxyContin that is more difficult to 
crush and snort. This inadvertently 
drives addicts to heroin.
HEROIN
The epidemic increases over 
time. Addicts’ demographics shift 
from poor, predominantly black 
communities to more white, middle- 
to upper-class communities.
FENTANYL
Dealers realize cutting heroin with the 
far more potent, cheaper, lab-made 
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users a better — but often fatal — high.
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Center directors would not read these surveys; 
instead, responses would go to Cicero’s research 
group at the School of Medicine. is helped 
legitimize the project and prompted addicts to be 
more forthcoming with their answers. 
“Addicts felt the survey was for a good purpose 
and that we were trying to solve a problem that 
they had,” Cicero said. “ey’re desperately 
looking for someone who will either help them 
with their treatment or maybe prevent this crisis 
in the rst place.”
Over the past two decades, Cicero’s team 
has sent out condential questionnaires to 
approximately 150 drug treatment centers 
nationally to better understand addiction. Most 
clients choose to remain anonymous, but some 
agree to be identied and even participate in 
lengthier interviews with Cicero. 
Survey data is collected in real time. is 
enables the researchers to put their “ears to the 
ground,” identify new types of drug abuse and 
quickly inform regional rst responders and 
agencies about impending threats.
“I don’t think there’s anyone that does a 
more thorough and accurate survey of drug 
abuse than Ted Cicero,” said John Burke, past 
president of the National Association of Drug 
Diversion Investigators and a retired Ohio police 
commander who served on the force more than 
50 years. He now runs Pharmaceutical Diversion 
“Now all of a sudden we had a pure version 
of oxycodone that didn’t contain any additives,” 
Cicero said. e maker of this extended formula  
and the Food and Drug Administration (FDA) 
later stated that they did not foresee addicts’ 
workarounds. 
With a new emphasis on curing pain and  
the discovery of a more potent delivery method, 
other pharmaceutical companies began producing 
variations of these pain pills. Doctors became 
more willing to prescribe opioids in larger 
amounts. Many of these prescriptions would go 
unused, stored in medicine cabinets and end up 
getting stolen, sold and diverted to the streets. 
“Now you have a ready supply of it on the street 
because physicians were doing their job and 
treating pain, but had no indication that this  
was going to lead to trouble,” Cicero said. 
Gathering abuse data
In the 1990s, Cicero worked on an FDA advisory 
committee evaluating the abuse potential of 
drugs undergoing approvals. Before long, a drug 
company sought his help in gaining federal 
approval for a new opioid named tramadol, or 
Ultram. To determine its abuse potential, Cicero 
suggested sending surveys to U.S. drug treatment 












David Tan, MD (standing),  
chief of the emergency medical  
services section, explains  
naloxone administration to  
Missouri park rangers at 
Babler Memorial State Park 
in Wildwood. Naloxone, or 
Narcan, is a nasal spray that 
works as an opioid antidote. 
Frontline responders, such as 
highway patrol officers, park 
rangers and conservation 
agents, now keep Narcan at 
their disposal.
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Education Inc., an organization that educates  
law enforcement and health professionals about 
the dangers of diversion (the illegal the and sales 
of pharmaceutical drugs). 
Cicero’s studies helped verify opioid abuse 
trends in Ohio, a state hit particularly hard by  
this crisis. e ndings “over and over are 
consistent with what we see on the street,” Burke 
said, and have been a reliable source for educating 
the public about the changing face of opioid abuse.
Cicero and his colleagues also publish survey 
data and analyses in national scientic journals 
and keep the FDA abreast of their ndings. While 
the agency collects its own data, the gathering 
process extends over much longer time periods 
and is oen published years later. 
A new drug of choice
When doctors realized the NEJM letter was wrong 
and that there actually was a very large abuse 
potential for painkillers, they began limiting the 
quantity of pills they prescribed. Purdue Pharma 
also switched to an abuse-deterrent formulation of 
OxyContin that was much more dicult to crush 
and snort. ese changes kept some of the pills 
o the streets and slowed their abuse but had the 
unintended consequence of forcing addicts, who 
were unlikely to stop using drugs altogether, to 
nd a substitute. at substitute, for the most  
part, was heroin. 
In 2014, Washington University was the rst 
to signal this shi from prescription opioids to 
heroin, a cheap and easily accessible alternative. 
As more people used heroin, the less stigmatized 
it became. Suddenly heroin started showing up 
in auent suburban neighborhoods and schools. 
Cicero’s surveys uncovered these shis in users’ 
demographics: Half of those who began using 
heroin before 1980 were white, but over the past 
decade nearly 90 percent of those who began  
using were white. 
e surveys also helped reveal the use of 
fentanyl, a synthetic opioid, which began to show 
up in much of the heroin responsible for overdoses, 
and carfentanil, a derivative of fentanyl that is 
used to tranquilize elephants. Fentanyl and its 
derivatives are 50 to 100 times more potent than 
heroin, provide a more intense “high” for the user 
and are relatively inexpensive to make in the lab. 
Knowing fentanyl and similar drugs 
were becoming a problem has helped federal 
authorities to better monitor availability and 
block importation of the drugs into the country. 
First responders also have learned to use caution 
as some of these drugs can be deadly — even in 
small amounts — if accidently inhaled at the  
scene of an overdose.
Narcan is an antidote that rapidly reverses the effects of an opioid overdose;  
it has no adverse effects if administered to a person who is not overdosing.  
The drug is available at many pharmacies without a prescription.
Check for signs of an 
overdose
Signs include: lack of responsive-
ness, shallow breathing, pinpoint 
pupils, blue/gray lips or fingernails, 
clammy/pale face. Call 911.
Administer Narcan
If, based on these signs, you suspect 
an overdose, administer Narcan nasal 
spray in one nostril. The spray is 
absorbed through the blood vessels 
in the nasal membranes. 
Monitor response
The drug then travels to the brain, where  
it replaces the opioid molecules that  
are bound to opioid receptors. Narcan 
works to revive victims in 2-5 minutes.  
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Moving beyond fear
All of this misuse has had a chilling eect on 
doctors, who now may be resistant to prescribing 
opioids, even to those who need them. “Physicians 
are really at a disadvantage now not knowing  
who to treat and who not to treat,” Cicero said. 
“Given all the publicity surrounding this problem, 
and now the escalation to heroin, most physicians 
have gotten to the point where they’re afraid to 
prescribe these medications.” 
Doctors must learn to ask questions about 
patients’ previous history of drug use, alcohol 
use and smoking, as well as any past anxiety or 
depression, Cicero said. ese are all potential 
markers of abuse. Cicero also believes physicians 
need to be more cognizant about the amount of 
opioids they are prescribing: Is a 30-day supply 
really necessary in most cases? 
To help improve opioid prescribing practices, 
Cicero suggests that medical schools add opioid 
and alternative pain management, as well as 
addiction education, to the curriculum. Medical 
students graduating today generally are not 
equipped to deal with the crisis.
“Most physicians don’t really know how to 
eectively treat pain. We don’t teach them,” Cicero 
said. “ey don’t know how to manage pain and they 
certainly don’t know the signs that a potential patient 
is going to be vulnerable or susceptible to abuse.” 
Evan Schwarz, MD, assistant professor of 
emergency medicine, and his team are on the 
frontlines, treating at least two to three addicts a 
night in the Barnes-Jewish Hospital Emergency 
Department (ED). When possible, the team 
administers Suboxone, a medication that limits 
cravings, as part of a project funded by the 
Behavioral Health Network of Greater St. Louis.
General practitioners can undergo training to 
learn how to administer Suboxone and similar 
addiction treatment drugs, Schwarz said. is way, 
they can treat regular patients who show signs of 
opioid abuse on an outpatient basis, which could 
help relieve the strain on treatment centers. 
Providing patients with realistic pain 
management expectations can go a long way  
in preventing addiction, Schwarz said. Zero 
pain may not be achievable and patients may 
need to endure some measure of pain in certain 
circumstances. When appropriate, physicians  
and patients should seek out alternative forms 
of pain control via pain management specialists, 
physical therapists, meditation and so forth.  
“We try to let patients understand that we’re  
going to do our best to control their pain and give 
them realistic expectations for what we can do,” 
he said. “And even if we’re prescribing opioids, 
we want to do it in a safe and limited way because 
these medications do have risks.” 
Washington University emergency physicians 
David Tan, MD, and Jerey Siegler, MD, also 
are leading regional medical training for rst 
responders on naloxone administration. Naloxone, 
or Narcan, works as an opioid antidote, reversing 
an overdose within seconds. Narcan has saved 
nearly 27,000 lives, according to the CDC.
e training is part of a federal grant from 
the Substance Abuse and Mental Health Services 
Administration, in partnership with the National 
Council on Alcoholism and Drug Abuse. 
e program educates rst responders about 
misconceptions surrounding opioids. “Some 
people, when they start the training, are sitting 
there with a scowl on their face, with their arms 
crossed,” said Tan, also chief of the emergency 
medical services section. “And they think that these 
heroin addicts can choose to stop like we choose to 
stop at a red light and go at a green light. And it’s 
just not that easy for many of these people.” 
To help prevent repeat overdoses, something 
the responders see all too oen, the training also 
emphasizes the importance of referring addicts to 
treatment centers, Tan said. 
Even with treatment, though, it is not easy 
to recover from opioid addiction. “e average 
number of times our patients have been in 
treatment is 4.8, almost ve times,” Cicero said. 
“And some people are sober for years and then  
slip back into it because that feeling that they get 
with this drug — how it makes them feel like a 
better person — is going to be with them forever.
“e ability to understand this, to get 
qualitative data has turned out to be extremely 
important. And we’re now on the leading edge 
of being able to use these data methods to 
understand more about what motivates abuse  
and how to mitigate it.”
“ Physicians are really at a disadvantage  
now not knowing who to treat and 
who not to treat.”  — Theodore Cicero, PhD
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Cells near the edge of a mouse 
kidney glow red, a sign that they 
are starved for oxygen. This is an 
important clue for researchers 
studying how the kidney responds 
to injury. Image taken on Zeiss 
Axioscan Z1 Automated Slide 
Scanning System.
Imaging center brings
the science of life to light
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“It’s a complicated beastie,” said Fitzpatrick, 
grinning. He is director of the Washington 
University Center for Cellular Imaging, known  
as WUCCI and pronounced Wookiee. 
He has spent the better part of the spring and  
summer overseeing the installation and calibration  
of the $7.2 million microscope, and he will put it  
through weeks of testing before making it available  
to the center’s clients later this fall. e machine 
is the cornerstone of a signicant investment 
in cellular imaging. Advances in the eld are 
transforming biomedical research, and WUCCI is 
keeping Washington University at the forefront.
Introducing the WUCCI
WUCCI sprawls across 6,000 square feet in the 
basement of the McKinley Research Building (to 
be renamed the Debra and George W. Couch III  
Biomedical Research Building) on the Medical 
Campus. It houses 15 of the most advanced 
microscopes, as well as banks of high-powered 
computers that are needed to analyze the 
mountains of data they produce.
e scopes can take 3-D images of viruses, make 
movies of living neurons as they signal one another, 
visualize the beating hearts of small animals 
such as worms and sh and map the structure of 
proteins down to the location of each atom.
Since the center’s establishment in 2015, 
researchers have imaged everything from living 
zebrash and buttery eyes to plastic catheters 
and rocks.
Today, more than 500 Washington University 
researchers representing some 220 labs use the 
center, and Fitzpatrick is hoping to draw more. 
Cornerstone of biology
When Anton van Leeuwenhoek looked through 
the rst microscope more than 300 years ago and 
saw legions of previously unimagined life forms 
wriggling underneath, he established one of the 
foundations of modern biology. 
“Imaging is one of the cornerstones of biology 
and biomedical science,” said Azad Bonni, MD, 
James Fitzpatrick, PhD, adjusts the wiring inside the center’s 
new cryo-electron microscope. The instrument visualizes objects 
as small as a few billionths of a meter, allowing researchers to 
map the location of each atom in a protein.
 
Twelve feet tall and weighing several tons, the microscope capable of generating the voltage of a stun gun looms over James 
Fitzpatrick, PhD, as he circles it, dely opening 
latches and detaching panels. A door on the side 
swings open, revealing a tangle of wires and, near 
the top, a shelf the size of a tape cassette. When the 
machine is fully built and turned on, a robotic arm 
will reach down, pick up experimental samples 
placed on the shelf and insert them into a column 
deep inside. ere, the samples will be bombarded 
with electrons. 
And the invisible will be unveiled. 
is instrument that Fitzpatrick has so pain-
stakingly unsealed is a top-of-the-line cryo-electron  
microscope. It is capable of magnifying the living 
world’s tiniest structures — bacteria, viruses and 
biomolecules — a million or more times, bringing 
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PhD, the Edison Professor and chair of the 
Department of Neuroscience. “Whatever  
questions we’re trying to answer, it all comes  
down to cells, because they are the fundamental 
unit of living things.”
Modern research microscopes are as far 
from Leeuwenhoek’s single-mounted lens as 
smart phones are from Alexander Graham Bell’s 
invention. ey not only take snapshots of cells 
mounted on slides, they can record movies of a 
fertilized egg developing into an embryo, or of an 
immune cell chasing a bacterium. ey can focus 
deep inside bones, tumors and even small animals, 
allowing scientists to see cells and tissues in their 
natural environment. ey reveal our DNA. 
Microscopy makes the invisible visible.
WUCCI builds on the strengths of the 
departments of Neuroscience and of Cell Biology 
and Physiology, which operated separate imaging 
facilities for a number of decades. About ve years 
ago, at funding renewal time, department leaders 
questioned whether to re-establish separate facilities 
or join together. “It occurred to us that it might be 
a good idea to create a collaborative center greater 
than the sum of its parts,” Bonni said. 
e neuroscience imaging facility specialized 
in light microscopy, which allows researchers to 
attach uorescent markers to specic molecules or 
cells, color-coding their images. Such technology 
suits researchers who oen study how cells respond 
to cues, and circuits of cells and the synapses 
connecting them. 
Cell biologists lean more heavily on electron 
microscopy, which images objects tens to thousands 
of times smaller than cells. Electron microscopes 
reveal precisely how the essential molecular 
machinery of the cell operates and how molecules 
involved in disease might be targeted with drugs.
Members of both departments — Paul Taghert, 
PhD, and Bonni from Neuroscience, and Helen 
Piwnica-Worms, PhD, Robert Mecham, PhD, 
David Piston, PhD, and Phyllis Hanson, MD, PhD, 
of Cell Biology and Physiology — advocated for 
this core center and engaged in discussions across 
the medical school. Taghert and Hanson traveled 
the country, gathering the best ideas from leading 
imaging facilities. Ultimately, Fitzpatrick was 
recruited from e Salk Institute in San Diego.  
“We sold him on the idea that he could build 
something big here,” Bonni said.
Institutional resource
Modern imaging is key to understanding and 
treating many diseases. irty years ago, there 
were no microscopes that could map the blood 
vessels inside a solid tumor, or trace the outlines 
of each molecule in a virus’s shell. at technology 
now hums and clicks and reshapes medicine in 
Fitzpatrick’s center, and researchers increasingly 
rely on it. With every technological improvement, 
microscopy has grown more central to biological 
research … and more expensive. 
Outlook  23
To study how sound is 
transmitted from the ear to 
the brain, researchers stained 
specialized sound-detecting 
cells (blue) and their synapses 
(red/green) in a mouse inner 
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“Many researchers need access to a wide 
range of imaging tools but could never aord to 
have them in their lab,” said Piston, the Edward 
Mallinckrodt Jr. Professor and head of Cell 
Biology and Physiology. “Oen that means that 
young investigators have to make compromises 
on their choice of projects, but having access to 
WUCCI allows them to think more broadly.”
Furthermore, eectively using the high-tech 
equipment requires skills that can be dicult for 
small research groups to obtain.
“As the technology becomes more complicated, 
it takes more and more specialized expertise to 
get the most out of it,” Piston said. “In a large 
central facility, we can aord to hire and train 
the right specialists.”
Fitzpatrick likes to call the facility a one-stop 
shop, because the seven full-time sta members 
— all scientists themselves — are prepared to 
help with any stage of research.
“I have sat down with people at WUCCI and 
talked about basic cell biology,” said Cliord 
Luke, PhD, an associate professor of pediatrics 
who has used the center’s super-resolution light 
microscopes. “If you tell them what question 
you’re trying to answer, they will help you gure 
out the best way to do the experiment and which 
microscope is best suited for it.”
WUCCI has a suite devoted to sample 
preparation, containing equipment such as 
diamond knives sharp enough to cut extremely 
thin slices of tissue. Just as sets for TV shows 
Imaging life
Modern microscopes can image objects 
ranging in size from insects to molecules. 
T I S S U E
B A C T E R I A
P R O T E I N
UNIT OF MEASUREMENT
1 cm = 1 centimeter =1/100 of a meter
1 mm =1 millimeter =1/1,000 of a meter
1 µm =1 micrometer=1/1,000,000 (millionth) of a meter
1 nm =1 nanometer =1/1,000,000,000 (billionth) of a meter





O R G A N I S M
XRAY 
MICROSCOPY
X-rays can penetrate 
deep into the body to 
image internal organs, 
tissues and whole 




The oldest form of imaging, 
light microscopy illuminates 
tissues, cells and some 
bacteria. Molecular labels 
that fluoresce in every color 
of the rainbow allow 




Electron microscopes use 
a concentrated beam of 
electrons to visualize the 
very smallest objects – 
bacteria, viruses, molecules, 
even atoms. 
X-ray tomography detects an emulsion of gold 
nanoparticles, tracing the network of blood vessels 
in a mouse’s lungs and heart. Image taken on Zeiss 
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became more realistic as high-denition TVs 
became commonplace, sample prep has become 
more important — and more elaborate — as 
microscopy has improved. 
“When the resolution wasn’t as good, the 
quality of the sample prep didn’t matter as much,” 
Fitzpatrick said. “If something was a bit distorted, 
you couldn’t tell. ese days, the quality of sample 
prep is of paramount importance.”
Immense computing power is required to 
process the complex datasets that come o the 
microscopes. Powerful computers line one wall of 
the center, and center sta can assist with analysis. 
Pushing the limits
WUCCI is the latest step in a long history of 
imaging strength and innovation at Washington 
University. e rst electron microscope built in 
the U.S. was designed and constructed by Gordon 
H. Scott, PhD, associate professor of cytology in 
the Department of Anatomy, around 1935. 
More recently, Timothy Holy, PhD, the Alan 
A. and Edith L. Wol Professor of Neuroscience, 
developed a form of  light-sheet microscopy, which 
allows scientists to view thousands of cells at a 
time. Holy used this variation on the technique to 
scan more than 10,000 cells in a mouse’s nose to 
nd the rare ones that turn on when the animal 
snis a particular pheromone.
Now, WUCCI sta are pushing the next 
frontier of imaging: virtual reality. 
“We have microscopes that produce these 
beautiful, detailed 3-D images, but then we  
display them on a at 2-D screen,” Fitzpatrick  
said. “We think that if people can take their 
results, hold them in their hands, turn them 
around, and look at them from all angles it will 
generate new ideas and understanding.”
Michael Shih, PhD, a center research specialist, 
has begun developing soware that can convert 
researchers’ 3-D images into a virtual reality. e 
goal is to create an immersive environment to 
navigate biological samples ranging in scale from 
molecules to organ systems. 
Although a virtual still image allows 
researchers to manipulate and inspect a virtual 
object, a virtual reality movie would allow 
people to watch from the inside as a biological 
process took place. Imagine standing at a cell’s 
midline and watching as the chromosomes lined 
up around you and then pulled apart into two 
daughter cells. 
“Hardly anyone is working on the applications 
of virtual reality in microscopy,” Fitzpatrick said. 
“is is something we are working on oering that 
no other imaging facility can do.”
Looking ahead
WUCCI has the potential to transform how 
biology is done at Washington University. e 
center ranks among the top ve best in the U.S., as 
measured by the quality of the microscopes and the 
power of the computers. Staying in that position 
requires an ongoing commitment. Increasingly, 
other departments are contributing specialized 
equipment. e cryo-electron microscope, for 
instance, was jointly purchased by the oces of 
the provost and the medical school dean and other 
medical school departments led by Biochemistry & 
Molecular Biophysics and Cell Biology & Physiology.
“More and more, biomedical research depends 
on new technology,” Piston said. “ere has 
been a lot of expertise in imaging at Washington 
University for a long time, but it has been 
distributed in dierent departments and centers, 
and it was dicult for researchers to nd all the 
parts they might need, or to even learn that those 
were available. “With WUCCI, we now have the 
ability to access the newest technology through 
shared contributions.”
Wearing a headset and hand 
controllers, Michael Shih, PhD, 
explores the virtual reality 
scene he has created from a 
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Jerey Gordon, MD, studies 
the microbial communities 
that colonize the human gut. 
His work has revolutionized 
understanding of how gut 
microbes shape human health 
and disease. Talented students 
and postdoctoral researchers 
such as Carrie Cowardin, PhD 
(left), and Vanderlene Kung, MD, 
PhD, assist him.







The advent of genomic medicine  has created the need for a new type of scientist — one able to translate 
genetic data into clinically relevant 
research that improves human health.
For nearly 15 years, the interdisciplinary 
Center for Genome Sciences & Systems 
Biology at the School of Medicine has 
provided a fertile proving ground for this 








A L U M N I  &  D E V E L O P M E N T
26  Washington University School of Medicine Autumn 2017
173043_p26-36_IBC_MAD_v13_cc17.indd   26 9/1/17   7:59 AM
outlook.wustl.edu Outlook  27
Working at the interface of computational 
and experimental biology, the center’s faculty 
members and students have developed novel 
approaches to address some of the world’s  
greatest health challenges, including obesity, 
childhood malnutrition and antibiotic resistance. 
To help advance the center’s innovative 
research and training programs, a St. Louis  
family with a long history of investing in the 
School of Medicine has contributed $10 million  
to Washington University. is gi from the 
Edison family through the Harry Edison 
Foundation will create the Edison Family Fund  
to support the Center for Genome Sciences & 
Systems Biology and the work of its director, 
Jerey Gordon, MD, the Dr. Robert J. Glaser 
Distinguished University Professor. In recognition,  
the center is being named the Edison Family 
Center for Genome Sciences & Systems Biology.
 “is gi will serve as an important catalyst 
for the School of Medicine’s personalized medicine 
initiative,” said Chancellor Mark S. Wrighton.  
“It will enhance our eorts to understand how 
our genetic dierences inuence our well-being 
and disease risk and empower a new generation of 
scientists to combat illnesses that aect millions.”
e Harry Edison Foundation’s rst gi to the 
School of Medicine, made in 1967, established 
a professorship in surgery as a tribute to the 
foundation’s namesake. Harry Edison, one of  
ve brothers who founded a chain of shoe stores 
that became the fashion conglomerate Edison 
Brothers Stores, was a noted philanthropist  
and civic leader.
 “For 50 years, the Edison family has been 
committed to supporting St. Louis’ greatest 
institutions, including Washington University 
and its School of Medicine,” said Andrew 
Newman, Harry Edison’s great-nephew, a  
trustee of the Harry Edison Foundation and  
a longtime member of the university’s Board  
of Trustees and member of the School of 
Medicine National Council. “We are excited  
to play a role in advancing the important work 
being done at the Center for Genome Sciences  
& Systems Biology. I have known Je Gordon  
for many years, and I have great condence in  
his leadership and research.”
Groundbreaking research
Gordon is internationally recognized for his 
pioneering role in establishing a eld of research 
devoted to the human microbiome. His work 
focuses on the trillions of microbes that live in 
the gut, where they process foods and synthesize 
vitamins and nutrients that human cells can’t 
manage on their own. Groundbreaking studies by 
Gordon and his trainees have linked these microbes 
and their genes to disease and good health.
Aer initially identifying the 
relationship between dysfunctional 
gut microbiomes and obesity more 
than a decade ago, Gordon and his 
students expanded their research to 
address childhood malnutrition, the 
leading cause of death worldwide in 
children under the age of 5. ey have 
formulated new types of food-based 
therapies that are designed to repair 
the gut microbiota in malnourished 
children. Working with collaborators 
in Bangladesh, they are beginning 
to test the eectiveness of these 
therapeutic foods.
 “is gi from the Edison 
Foundation will enable us to make 
strategic investments that allow our 
research community to evolve and 
remain vibrant,” Gordon said. “I think 
it is a wonderful expression of trust on 
the part of the Edison family. eir belief in our 
center and our capacity to improve the health and 
well-being of people around the world encourages 
us to keep moving forward, especially in a time of 
uncertainty regarding federal funding for research.”
Family’s legacy
Previous gis from the Harry Edison Foundation 
have supported a variety of initiatives and 
programs at the School of Medicine, including 
diabetes research, stem cell and developmental 
biology research, and the construction of the Eric 
P. Newman Education Center, named in honor 
of Andrew Newman’s father, a 1935 graduate 
of Washington University’s School of Law. e 
foundation also established a second professorship — 
the Edison Professorship in Neurobiology — in 1977.
Members of the Edison family have provided 
signicant personal support and leadership across 
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Each year, the Washington University Medical Center Alumni Association 
honors a select group of graduates, faculty members, former residents 
and fellows for their professional achievements, community service and 
dedication to the university. Here are the 2017 recipients:
Alumni Association awards
n  David Schlessinger, PhD 
Distinguished Service Award
Schlessinger is a National Institutes of Health 
(NIH) Distinguished Investigator at the 
Laboratory of Genetics at the National  
Institute on Aging (NIA). He is internationally 
recognized for his pioneering work in basic 
molecular biology, including the mechanism 
of action of antibiotics and the application 
of human genetics and genomics to better 
understand disease.
In 1960, Schlessinger earned a doctoral  
degree from Harvard University, where he 
worked for DNA co-discoverer and Nobel 
laureate James Watson. Following two years  
of postdoctoral training at the Pasteur Institute, 
Schlessinger joined Washington University, 
where he served as professor of molecular 
microbiology, of genetics and of microbiology  
until 1997.
Schlessinger rmly established the study  
of human genetics at Washington University 
and is credited with positioning the school at 
the forefront of genetics research before he later 
moved to the NIA.
n  Paul S. Simons, MD ’67 
Distinguished Service Award
Simons, associate professor of pediatrics, is 
known throughout the pediatric community 
for his tireless dedication to the treatment of 
children and adolescents with developmental 
and behavioral disabilities. 
Long before autism and attention decit 
disorder (ADD) were in the national spotlight, 
Simons not only was identifying and treating 
children with these disabilities, he also was 
training numerous medical students and 
residents in developmental and behavioral 
pediatrics.
A devoted advocate of his patients, Simons 
also championed research, contributing 
heavily to the enrollment of clinical research 
subjects into research protocols at Washington 
University. e eld of pediatrics has beneted 
greatly from the school’s psychiatric studies of 
depression, autism, bipolar disease and ADD.
Col. Thomas R. Burklow J. William Campbell Charles W.M. RobertsDavid Schlessinger Gary A. RatkinPaul S. Simons
To read more about 
the recipients, go to 
wumcnews.org/ 
2017awards
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Alumni Association awards
Charles W.M. RobertsGary A. Ratkin Scot G. Hickman Richard W. McCallum Janet B. McGillJe M. Michalski
n  Thomas R. Burklow, MD ’87 
Alumni Achievement Award
Burklow, director for Population Health and 
HEDIS Compliance at Walter Reed National 
Military Medical Center, was recognized for 
30 years of outstanding service as a clinical, 
academic and administrative leader in the 
nation’s agship military centers. 
 
n  J. William Campbell, MD ’77, HS ’80 
Alumni Achievement Award
Campbell is medical director for St. Luke’s 
Medical Group and professor of clinical 
medicine at the School of Medicine. Among  
the earliest physicians in St. Louis to treat 
patients with HIV/AIDS, Campbell helped 
establish the medical school as a leading center 
for care of HIV-infected patients. 
 
n  Gary A. Ratkin, MD ’67, HS ’72 
Alumni Achievement Award
Ratkin, an associate professor of clinical 
medicine, is a distinguished oncologist, medical 
ethicist and palliative care physician. His ideas 
regarding living longer and better through 
palliative care have served as the basis for 
teaching how to care for chronically ill patients.
 
n  Charles W. M. Roberts, MD/PhD ’95 
Alumni Achievement Award
Roberts is director of the Comprehensive 
Cancer Center and executive vice president 
at St. Jude Children’s Research Hospital 
in Memphis. An international expert in 
cancer epigenetics and a dedicated pediatric 
oncologist, colleagues regard him as an 
accomplished leader who moves seamlessly 
from research to clinical care.
n  Scot G. Hickman, MD ’70, HS ’77 
Faculty Achievement Award 
Hickman, a professor of medicine, is renowned 
for outstanding mentorship of medical students, 
residents and junior faculty. He has taught 
the hematology section of the medical school 
curriculum for 30 years and the oncology 
section for 20. Many students say he inspired 
them to become hematologists and oncologists.
 
n  Jeff M. Michalski, MD, HS ’91 
Faculty Achievement Award
Michalski, the Carlos Perez Distinguished 
Professor of Radiation Oncology, is a global 
leader in the treatment of prostate and  
pediatric cancers. He was honored for his 
important contributions to radiation oncology 
and to the improvement of patient care at  
the Alvin J. Siteman Cancer Center.
 
n  Richard W. McCallum, MBBS, HS ’72 
Resident/Fellow Alumni Achievement Award
McCallum is professor and founding chair of the 
Department of Internal Medicine at Texas Tech 
University Health Sciences Center and chief of 
its Division of Gastroenterology, Hepatology 
and Nutrition. He is recognized as a premier 
thought leader in neurogastroenterology and 
gastrointestinal motility.   
 
n  Janet B. McGill, MD, HS ’87  
Resident/Fellow Alumni Achievement Award
McGill, a professor of medicine, has 
made important contributions to further 
the understanding and management of 
diabetes mellitus. She has led more than 200 
clinical trials and helped develop the most 
recent American Association of Clinical 
Endocrinology diabetes treatment guidelines. 
173043_p26-36_IBC_MAD_v13_cc17.indd  29 8/30/17  11:26 AM
Autumn 2017
Shining
   example
Ophthalmology department 
named for John Hardesty
By all accounts, St. Louis ophthalmologist John Franklin Hardesty, MD (1887-1953), was a hero. As a member of the U.S. Army 
Medical Corps during World War I, he risked his 
life to help soldiers on the front lines. Aer the war, 
he sent assistance to Polish and Russian soldiers he 
met while being held as a prisoner of war in 
Germany. And as a physician, he helped pioneer 
glaucoma treatments, provided free care to those  
in need and advocated for laws to benet the blind. 
“When he died, so many people came to his 
funeral,” said Jane Hardesty 
Poole, AB ’61, Hardesty’s 
daughter. “Some of his patients 
were in tears because he had 
saved their or their child’s 
eyesight. My mother  
and I had no idea 
he had helped so 
many people.”
During World War I, Hardesty 
(seated) helped several soldiers 
escape from a prisoner of war camp 
in Villingen, Germany. One of the 
men, Edouard Issacs (right), who 
changed his surname to Izac, went 
on to become a U.S. Congressman 
from California.
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To honor her father’s memory and legacy 
of service, Poole has committed $10 million to 
the Department of Ophthalmology and Visual 
Sciences. In recognition, the department will be 
renamed the John F. Hardesty, MD, Department  
of Ophthalmology and Visual Sciences. 
 “Our department has a long history of 
advancing understanding of eye diseases and 
vision loss, particularly in the area of glaucoma,” 
said Todd Margolis, MD, PhD, the Alan A. and 
Edith L. Wol Distinguished Professor and department 
chair. “It is tting that the department now will bear the 
name of a man whose life’s work involved preserving vision 
and improving the quality of life for glaucoma patients.”
e gi will support ophthalmology research, clinical 
care and innovative training programs, and will help the 
department recruit and retain outstanding physician-scientists.
One of 12 children, Hardesty was born in Wineld, 
Missouri. He earned bachelor’s and medical degrees from 
Saint Louis University in 1914, and completed an internship 
and residency at St. Louis City Hospital. He had just begun 
to practice medicine in St. Louis when the U.S. entered 
World War I in April 1917. 
Aer joining the U.S. Army Medical Corps, Hardesty 
was among the earliest group of surgeons to volunteer to 
serve with the British Army as a member of the Seaforth 
Highlanders, an infantry regiment associated with the 
northern Highlands of Scotland. During a erce battle in 
northwest France, the German Army captured Hardesty  
while he was manning an aid post on the frontline trenches. 
For eight months, he was held as a prisoner of war. 
Hardesty’s role in a daring escape from the Villingen 
camp in October 1918 was widely reported in newspapers 
aer he was honorably discharged from the 
Army. He devised a successful plan to distract 
guards and short-circuit lighting along a 
barbed-wire fence so three fellow prisoners 
could make their way through it. e Germans 
never discovered his role in the plot. For his 
heroism, Hardesty received the Victory Medal. 
Hardesty was a faculty member at Saint 
Louis University Medical School from 1920 
until his death, and also served as acting chair 
of its ophthalmology department. 
In 1934, he wrote a thesis for membership in the 
American Ophthalmological Society that proposed a new 
way to treat glaucoma using systemic medications such as 
epinephrine. His research represented the rst attempt to 
treat glaucoma in this way. Epinephrine in eye drop form 
still is used to treat the disease. Hardesty’s work laid the 
foundation for the development of the oral drug Diamox 
for glaucoma in the 1950s by Washington University 
ophthalmology professor Bernard Becker, MD. 
Hardesty provided free eye care to residents of the Blind 
Girls’ Home, Missouri School for the Blind and other schools 
and orphanages, and to patients throughout the region. 
Poole, who was only 14 when her father died, remembers 
him as a kind and loving man. “I adored him,” she said. 
“We would walk down to dinner every night on our wide 
staircase with our arms around one another. He gave me the 
unconditional love that every child needs.”
“My father was modest and humble,” Poole added. “He 
wanted to be a doctor simply to help people. On top of his 
great ability, he gave freely of his time and resources. He 
stands as a shining example of what every doctor should be.”
In 2012, Jane Hardesty Poole established the John F. Hardesty, MD, Distinguished Professorship in Ophthalmology and Visual Sciences, now 
held by pediatric ophthalmologist R. Lawrence Tychsen, MD.  Poole credits  
Tychsen with saving her daughter Josephine’s eyesight.
Born with a developmental disability, Josephine is non-verbal and  
could not articulate what she was seeing on traditional eye tests. After 
consulting many doctors near their Manhattan home, Poole read an article 
in The New York Times highlighting novel ophthalmology treatments at 
Washington University. In 2004, she and her daughter traveled to St. Louis  
to meet Tychsen. Through surgery, he restored her vision to 20/40.
The experience convinced Poole that Washington University was  
the appropriate place to honor her father. “I want to honor him where  
it’s the best,” she said. — Hilary Davidson
Professor saved eyesight 
 of donor’s daughter
John Hardesty, MD
R. Lawrence Tychsen, MD, and Jane Hardesty Poole
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The Program in Occupational Therapy  is turning 100 years old in 2018. To celebrate,  Carolyn Baum, PhD, OTR, FAOTA, the program’s 
Elias Michael Executive Director, has created a scholarship 
challenge. All gis to the Occupational erapy annual  
fund will be matched by the $100,000 Carolyn Baum 
Centennial Challenge, which runs through Dec. 31, 2018. 
“At our 100th anniversary, the future of occupational 
therapy has never looked brighter,” Baum said.
Baum said she hopes the challenge will inspire alumni  
and friends to make a special gi, ensuring that the best  
and brightest students become the health-care leaders  
of tomorrow.
“e Baum Centennial Challenge lays the ground- 
work for another 100 years of superlative teaching and 
research at the Program in Occupational erapy,” said 
Centennial challenge supports scholarships in occupational therapy
David H. Perlmutter, MD, 
executive vice chancellor for 
medical aairs and dean of  
the School of Medicine.




Baum, a professor of 
occupational therapy, 
neurology and social work,  
has led the occupational 
therapy program since 1988. 
Her interdisciplinary perspective 
has helped guide the program, which U.S. News &  
World Report ranks as No. 1 in the nation. In 2017, the 
American Occupational erapy Association named Baum 
as one of 100 inuential people who have shaped the eld  
of occupational therapy. 
Baum earned a bachelor’s degree in occupational therapy 
from the University of Kansas, a master’s degree in health 
management from Webster University, and a doctorate in 
social work from the Brown School at Washington University.
“ At our 100th anniversary, 
the future of occupational  
therapy has never looked 
brighter.” — Carolyn Baum, PhD
Celebrating  
B Y  H I L A R Y  D A V I D S O N
Carolyn Baum, PhD
Cindy Mach, MSOT/MPH/S ’17, 
right, practices functional 
transfers and safe patient 
care in an acute care setting, 
while teaching assistant 
Brianna Beattie, OTD/S ’17, 
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1950S 
Emil Mantini,  
MD ’58, and his 
wife, Jane Mantini, 
NU ’57, moved to 
Tampa, Fla., where 
they enjoy living 
in an active senior 
center and watching 
sailboats gather in the bay once a week. 
They have three grown children: sons Franz 
and Louis, who live in Tampa and northern 
Florida, respectively, and daughter 
Elizabeth, who lives in the St. Louis area. 
The family recently gathered in Tampa 
to celebrate the couple’s 60th wedding 
anniversary. 
1960S 
Robert D. Porter, MD ’67, retired from 
nephrology practice in Topeka, Kan. In 
2013, he received the Bal Jeffrey Award 
for advancing medical care in northeast 
Kansas. Porter continues to serve as a senior 
Federal Aviation Administration aeromedical 
examiner and as a short-term medical 
provider to the Karen people along the  
Thai-Burma border. He is also a regular 
volunteer at the Abilene and Smoky Valley 
Railroad in Abilene, Kan.
Virginia Crandall, NU ’69, returned to 
work, providing women’s health care two 
days a week at a private practice in Colorado 
Springs, Colo. She also enjoys traveling and 
recently took a bike tour of New Zealand with 
friends and her daughter and son-in-law. 
1970S 
Thomas H. Gee, 
HA ’78, recently was 
recognized for 25 years 
of service as the chief 
executive officer of 
Henry County Medical 
Center in Paris, Tenn. 
Gee serves on the 
Board of Directors of the Tennessee Hospital 
Association and as an alternate delegate to 
the American Hospital Association. In 2016, 
Governor Bill Haslam appointed Gee to the 
Tennessee State Board for Licensing of Health 
Care Facilities.
Stephen Young, MD 
’78, was elected to the 
National Academy of 
Sciences in 2016 for his 
research on plasma lipid 
metabolism and diseases 
of the nuclear envelope. 
He is a cardiologist and 
distinguished professor of medicine and 
human genetics at the David Geffen School 
of Medicine at UCLA.
1980S 
Molly Eaton, MD ’81, spent more than 30 
years in Atlanta and is moving to Denver 
to serve as associate professor in infectious 
diseases at the University of Colorado Health 
Sciences Center, Anschutz Medical Campus.
David Pfeffer, MD ’83, is president of The 
Virginia Urological Society. He also serves 
as the Virginia State Society representative 
to the American Association of Clinical 
Urologists. He would like to encourage his 
former classmates to become politically 
engaged, both on a state and national level. 
He continues to practice independently in 
Warrenton and Culpeper, Va.
Jon R. Friedman, 
MD ’84, recently was 
inducted as a fellow of 
the American Society 
of Transplantation 
(AST) at the American 
Transplant Congress in 
Chicago and received 
a Distinguished Service Award from the 
AST in 2016. He is chief medical officer 
for Optum’s Population Health Solutions 
programs. Optum is the health services 
division of UnitedHealth Group. 
Find your friends.
Classnotes are organized first by  
year of degree/training completion 
and then in alphabetical order. 
How about you?
Share your news via the online 
form at wumcnews.org/classnotes. 
Submissions will be printed in 
a subsequent issue of Outlook 
magazine as space allows. Photos 
are welcome.
The Academic Pediatrics Association (APA) honored two 
Washington University alumni at its 
recent Pediatric Academic Society 
meeting in San Francisco. Elizabeth 
Reed Hanson, MD/GM ’07, assistant 
professor/clinical and associate 
program director of the Pediatric 
Residency Program at the University 
of Texas Health Science Center,  
San Antonio, received the APA 
Teaching Award for Faculty (Junior). 
Scott Hadland, MD ’09, director of 
the Urban Health and Advocacy 
Track of the Boston Combined 
Residency Program at Boston 
Medical Center and Boston Children’s 
Hospital, received the Residency 
Teaching Program Award. 
Alumni honored 
for teaching
Elizabeth Reed Hanson, MD/GM ’07, 
and Scott Hadland, MD ’09
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teaching methods to seventh-12th grade 
teachers in the Allentown school district. 
Their children, Raphael, 14, and Julian, 
10, are completing ninth and fifth grades, 
respectively.
Mary Iovine, PhD ’98,  
recently was promoted 
to professor at Lehigh  
University in the 
Department of 
Biological Sciences. 
Joni M. Kamiya, OT 
’99, participated in 
the 2015 Cornell Alliance for Science 
Global Leadership Fellows Program to 
help advocate for science-based policies 
and access to technology. Kamiya lives in 
Honolulu, and works professionally with 
senior adults and people with disabilities. 
Autumn 201734  Washington University School of Medicine
James F. Loomis Jr., HS ’88, EMBA ’97, 
recently moved to Washington, D.C., 
to become medical director at Barnard 
Medical Center, a non-profit primary care 
medical practice that focuses on nutrition 
to help prevent, treat and reverse many 
chronic diseases.
1990S 
Steve A. Harvey, LA ’88, MD ’92, HS ’96,  
has been working to build TMS St. Louis, 
a psychiatric subspecialty practice that 
provides transcranial magnetic stimulation 
(TMS) for patients with moderate or severe 
treatment-refractory depression.
Ari Berkowitz, GM ’93, professor of 
biology at the University of Oklahoma, 
wrote and published a neurobiology book 
for a general audience, titled “Governing 
Behavior: How Nerve Cell Dictatorships and 
Democracies Control Everything We Do,” 
from Harvard University Press.
Ajay Ahuja, MD ’95, recently took a role at 
Allergan Global as head of global and U.S. 
medical affairs. Ahuja will move with his 
family from Chicago to the New York City 
area, where the company is headquartered.
Michael Finley, PhD ’98, principal scientist 
at Janssen R & D in Spring House, Pa., leads 
a team of assay-development scientists 
in a newly revitalized high-throughput 
screening group for small-molecule 
drug discovery. This supports a range of 
therapeutic areas, including oncology, 
immunology and neuroscience. Fellow 
classmate and spouse, Audrey Ettinger, 
PhD ’98, is completing a first sabbatical 
semester after 15 years as a faculty member 
at Cedar Crest College in Allentown, Pa. 
In addition to her ongoing research and 
teaching commitments, Ettinger serves as 
an instructor in the Greater Allentown Math 
Science Partnership to bring inquiry-based 
Two Washington University alumni are helping hundreds of Mexican children and adults with disabilities obtain affordable prosthetic limbs, all-terrain wheelchairs 
and solar-powered hearing aids. 
Realizing the great need for these devices among low-income Mexicans, Burris 
“Duke” Duncan, BA ’54, MD, established the nonprofit company Arizona Sonora 
Border Projects for Inclusion (ARSOBO) in 2012. William Neubauer, MD ’69, who 
retired after 30 years as a general surgeon, now serves as the nonprofit’s board chair.
“If you lose a leg in Mexico, you are on crutches for life because prosthetics are 
extremely expensive,” Neubauer said.
ARSOBO promotes self-sufficiency by training and employing individuals with 
disabilities to construct medical equipment for themselves and others. These 
individuals are charged only the cost of the device, or what they can afford. ARSOBO 
recoups the remaining cost through charitable donations.
Neubauer has witnessed many miracles: adults who now work and lead normal 
lives; an 8-year-old who learned to talk after getting a hearing aid; and formerly 
homebound children with cerebral palsy who attend school.
“This is as important and satisfying to me as my 30 years in surgery,” Neubauer said.
Nonprofit empowers 
   Mexicans with disabilities
Clockwise from top left: William Neubauer, 
MD ’69; Burris “Duke” Duncan, BA ’54, MD; and 
wheelchair expert Gabriel Zepeda.
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Rebecca S. Sippel, 
MD ’99, associate 
professor and chief 
of the Division of 
Endocrine Surgery 
at the University of 
Wisconsin-Madison, is 
serving as president of 
the Association for Academic Surgery  
for the 2017-18 term.
2000S
Jeffrey Henderson,  
MD/PhD ’02, was 
promoted to associate 
professor of medicine 
and molecular 
microbiology at WUSM 
and elected to the 
American Society for 
Clinical Investigation. Henderson also 
received the Washington University 
Outstanding Faculty Mentor Award from 
the Graduate Student Senate.
Rachel Sieber, OT ’05, recently received a 
post-professional doctorate in occupational 
therapy from George Washington 
University.
Cawas Engineer, PhD ’06, completed 
a successful research project on crop 
abiotic stress signaling at the University 
of California, San Diego, and recently 
accepted the role of director of research at 
a start-up company in San Diego, where 
he will lead research on sensory input 
perception for drug discovery.
Keydra L. Oladapo, GM ’06, is currently 
serving a four-year term as U.S. diplomat in 
Southern Africa and received a promotion  
to branch chief of epidemiology, surveillance,  
monitoring and evaluation at the Centers 
for Disease Control and Prevention.
Stacy Kruse, LA ’03, MD ’08, recently 
returned to the U.S. with her husband and 
3-year-old son, after two and a half years 
of living in England. They have settled 
near Washington, D.C., where Stacy is an 
assistant professor of clinical medicine at 
MedStar Georgetown University Hospital.
Kimberly Dale, OT ’09, was selected to 
participate in the Veterans Administration’s 
Clinical and Administrative Leadership 
Development Institute. This is a 
competitive training and development 
program aimed at building leadership  
skills for higher roles in a health-care 
system. Dale lives in Detroit.
2010S
Tassy Hayden, LA ’07, MD ’11, is joining 
the staffs of Southampton Healthcare in 
St. Louis and BJC HealthCare. She looks 
forward to aiding in the education of 
WUSM students and serving the LGBT  
and HIV-positive communities, particularly.
Aaron M. Bertoni, MD ’12, completed 
residency training in anesthesia at the 
University of Washington, Seattle, and 
works part time at Island Hospital in 
Anacortes, Wash. He spends the rest of 
his time sailing the San Juan Islands, 
hiking the Pacific Crest Trail and crabbing 
in Puget Sound with his wife, Emily, and 
dog, Barney.
Raghav Govindarajan, 
HS ’13, recently gave 
four invited talks and 
was awarded the 
Clerkship Director 
Teaching Award, the 
A.B. Baker Teacher 
Recognition Award 
and the Patient Safety Award by the 
American Academy of Neurology at 
its national meeting in Boston. He is 
assistant professor of neurology at the 
University of Missouri-Columbia School 
of Medicine.
Louis Poppler, GM ’15, will begin a 
fellowship at the Mayo Clinic for advanced 
training in hand and nerve surgery. 
Darlene R. (Gollaher) Tilley, PT ’15, 
married Matthew Tilley, a student at 
Covenant Theological Seminary, in 
2016. She is celebrating two years of 
employment at SSM Health Physical 
Therapy and pursuing a certified 
strength and conditioning specialty.
Robert C. Drews, MD ’55, a 
professor emeritus of clinical 
ophthalmology, former 
member of the Board of 
Trustees and university 
benefactor, died Tuesday,  
May 9, 2017, at his home in  
St. Louis, following a stroke.  
He was 86.
Drews was an ophthalmologist,  
photographer, inventor of numerous  
medical instruments for the eye, and  
author of more than 500 journal articles,  
book chapters and books.
“His expertise in lens implantation and 
cataract surgery gained him international 
recognition and numerous invitations to  
teach advanced ophthalmic microsurgical 
techniques all over the world,” said Todd P. 
Margolis, MD, PhD, the Alan A. and Edith L. 
Wolff Distinguished Professor and head of  
the Department of Ophthalmology and  
Visual Sciences.
Drews graduated from the School of 
Medicine in 1955, did a residency in 
ophthalmology from 1956 to 1959, and 
became chief resident in 1958. After residency, 
he entered the Navy, serving at the U.S. Naval 
Hospital, Great Lakes, before returning to  
St. Louis to go into private practice and teach  
in the Department of Ophthalmology.
He is survived by his daughters Pamela 
Breitberg (Steven), Belinda Laupp and Jeanmarie 
Mertens (John); son, Carl Drews (Deborah); 10 
grandchildren and eight great-grandchildren.  
His wife, Lorene, preceded him in death.
Frederick D. Peterson, MD,  
a former professor of clinical 
pediatrics, died Thursday, 
March 2, 2017, in his sleep  
at a nursing home in 
Chesterfield, Mo. He was 85.
A longtime influential 
presence at St. Louis 
Children’s Hospital, Peterson began his affiliation 
with the university in 1957 as an intern and 
ultimately ascended to professor of clinical 
pediatrics in 1992. Peterson also maintained a 
private practice for more than three decades.
Peterson is survived by his brother, William 
Peterson, of Tallahassee, Fla.
continued on page 36 ...
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1940S 
Ernest J. Clark, MD ’48; Nov. ’16
Frank X. Dwyer, MD ’43; Feb. ’17
Robert H. Hall, MD ’45; March ’17
Dolores M. Moore, PT ’48; Feb. ’17
Betty Jo Petrofsky, NU ’48; Jan. ’17
Thomas E. Prosser III, DE ’45; April ’17
Clarence G. Schulz, MD ’45; Nov. ’16
1950S
Eric I. Anderson, MD ’52; Jan. ’17
Ruth C. Comens, MD ’50; Feb. ’17
Henry R. Dallam Jr., DE ’54, GD ’64; Jan. ’17 
Floyd M. Freeman, DE ’54; Feb. ’17
Dwayne R. Good, DE ’57; Dec. ’16
Howard R. Gray, MD ’52, HS; Feb. ’17
William G. McCuen, HS ’55; March ’17
Ralph B. Montgomery, DE ’54; March ’17
Marian P. Paxhia, NU ’57; March ’17
Jack Baer Rosen, LA ’55, DE ’58; March ’17
Raymond G. Schultze, LA ’55, MD ’59, 
HS ’63; April ’17
Richard E. Thompson, MD ’59; Jan. ’17
Betty McKee Von Rump, PT ’58; Feb. ’17
1960S
Henry E. Dupree, DE ’63; April ’17
Allan P. Fishbein, MD ’64; Sept. ’16
Koichi Fujii, HS ’62; March ’17
Gerald L. Howell, DE ’60; May ’17
Charles B. Manley, HS ’67; Nov. ’16
Thomas E. O’Keeffe, DE ’69; Feb. ’17
Nancy L. Pope, NU ’66; March ’17
Arthur Schneider, LA ’57, MD ’61; May ’17
Eli R. Shuter, MD ’60; April ’17
Thomas W. Yager, DE ’64; Feb. ’17
1970S
Barry Miller Farr, MD ’78; Feb. ’17
Kay Miller Rusche, MD ’77; Feb. ’17
Ernest P. Sutton, DE ’73; April ’17
Anthony Weisenberger, MD ’71; March ’17
1980S
Alexandre Carli, HS ’83; Jan. ’17
David Bradley Marrs, HS ’82; March ’17
2000S
Aaron Rogat, PhD ’02; April ’17
Jean Holowach Thurston, MD, a pioneering pediatric neurologist, 
died Saturday, April 29, 2017. She was 99 and about a month away 
from her centennial birthday. Thurston died of natural causes at a 
retirement home in University City, Mo.
A professor of pediatrics and of neurology, Thurston’s 
influential research has guided treatment of childhood seizure 
disorders. She led long-term studies examining anticonvulsant 
withdrawal in pediatric patients with epilepsy. Thurston’s research, 
published in 1972 in The New England Journal of Medicine, identified seizure 
recurrence risks. Those findings, which remain relevant today, contributed to therapies 
and diagnostic tools for childhood epilepsy.
Thurston continued her research for decades, establishing a neurochemistry lab, 
publishing her last paper at age 78 and attending professional seminars until a year 
before her death.
Thurston is survived by eight nieces. She was preceded in death by her husband  
of 38 years, Donald L. Thurston, MD, a professor emeritus of pediatrics. The couple 
collaborated on multiple research projects. 
For full obituaries, visit: 
wumcnews.org/obits
John M. Fredrickson, 
MD, former head of 
the Department of 
Otolaryngology, died 
Wednesday, April 5, 
2017, in Vancouver, 
Canada. He was 86.
Fredrickson came 
to Washington University in 1982 to serve  
as the Lindburg Professor and head of  
the Department of Otolaryngology, a 
position he held until 1998. He became 
an emeritus professor in 2002. 
Under Fredrickson’s leadership, the 
department grew in both clinical and 
research activities. His body of research 
included major contributions to the fields 
of vestibular neurophysiology, middle-ear 
implants and microvascular reconstructive 
surgery of the head and neck. After his 
retirement in 2002, Fredrickson returned 
to Vancouver and remained active in the 
field, helping to develop an implantable 
transducer for severe hearing loss. 
Fredrickson is survived by his wife, 
Alix, and his three children, Kristin, Lisa 
and Erik Fredrickson. 
Travis C. Mazer, a 
doctoral candidate 
studying molecular 
genetics and genomics, 
died unexpectedly 
Monday, April 24, 2017, 
in St. Louis. He was 25. 
His research focused 
on lysosomal biology in cellular stress and 
homeostasis, with a goal of understanding 
pathways to enhance cellular longevity. He 
worked in the lab of Abhinav Diwan, MD, an 
associate professor of medicine, and will be 
listed as an author on an upcoming research 
paper from Diwan’s lab. 
Earlier, he worked for two years as a 
research technician in the lab of Zachary 
Pincus, PhD, an assistant professor of 
developmental biology and genetics. 
A Kalamazoo, Mich., native, Mazer 
earned a bachelor’s degree in neuroscience 
from the University of Michigan.
He is survived by his parents, Wendy and 
Kevin Mazer; sisters, Mallory and Madison; 
brothers, Taylor, Trent (Kaitlin) and Tate; 
grandmothers, Jacqueline Roberts and Joyce 
Griffin, plus many aunts, uncles and cousins. 
...continued from page 35O B I T U A R I E S 
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Magical moment
Second-year medical student Hayley Motowski,
dressed as Belle from “Beauty and the Beast,”
presents a rose to Sarah Norwood, 9, of Arkansas,
who was awaiting surgery at St. Louis Children’s
Hospital. Students practicing for the 12th annual
School of Medicine musical —  including (bottom,
from left) Molly Grabill as Mrs. Potts, Motowski,
Chase Elwood as the Beast and Philip Frasse as
Lumiere — took their act to the hospital. While
there, Motowski even demonstrated a proper
princess wave. Sarah’s mom, Sherri Norwood,
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Witnessing history
The Washington University community 
gathered at Ellen S. Clark Hope Plaza to watch 
as the solar eclipse reached 99.99 percent 
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